Page 2 - Q3 Results

Kwality Wall's tanks 8% to its all-time low as Q3 net loss widens QoQ

On a quarter-on-quarter (Q-o-Q) basis, the company's net loss widened to ₹178.38 crore, as compared to a loss of ₹100.16 crore in Q2FY26

Astral surges 16% in 1 month, stock hits 52-week high in weak market

The management has maintained a double-digit volume growth forecast for Q4FY26 and FY27E, targeting 17-18 per cent EBITDA margin for Plumbing division and 12 -13 per cent for Paints & Adhesives.

Belrise Industries zooms 101% in 9 months; hits record high in weak market

Crisil Ratings believes that the Belrise group will maintain its strong position in the auto components industry backed by its established customer relationships and a diversified product portfolio.

Fractal Q3 profit rises 10.5% on strong healthcare and BFS growth

Fractal Analytics reported a 10.5% rise in Q3 profit to ₹102.6 crore, with revenue up 21% year-on-year as healthcare, life sciences and BFS demand lifted its first post-listing results

Bharat Electronics rallies 4%; why defence stock hit new high?

Thus far in the calendar year 2026, BEL has outperformed the market by surging 16%, as compared to 6.6% decline in the BSE Sensex.

Acutaas zooms 100% in 8 months; what's driving speciality chemicals stock?

Acutaas Chemicals management has revised revenue guidance upwards from 25 per cent to around 30 per cent growth for FY26.

Lupin rallies 12% thus far in CY26, outperforms market; here's why

In the past one month, Lupin has outperformed the market by soaring 6 per cent, as against 4.5 per cent decline in the BSE Sensex.

Sai Life hits record high in weak market; rebounds 5% from day's low

Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.

BSE Realty index hits 52-week low; DLF, Lodha, Sobha dip up to 4%

In the past one month, the realty index has tanked 10 per cent, as against 6 per cent fall in the BSE Sensex.

Sentiment shift: Earnings upgrade to downgrade ratio improved after Q3

There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth

Square Yards Q3FY26 revenue rises 47%, gross profit up 23% at ₹120 crore

Proptech firm Square Yards posted a 47 per cent year-on-year rise in Q3FY26 revenue, with Ebitda margin at 8 per cent and improved margins across business segments

Swiggy hits all-time low; stock tanks 26% thus far in CY2026

The stock price of Swiggy slipped 5% and hit an all-time low of ₹285.85 on the BSE in Monday's intra-day, thus fell below its previous record low of ₹297 touched on May 13, 2025.

Larsen & Toubro tanks 7%; stock records sharpest intra-day fall in 11 mths

Out of the international order book of ₹3.57 trillion, around 75 per cent is from the Middle East, L&T said in the Q3 earnings conference call on January 28, 2026.

GIFT City witnesses surge in fund commitments, investor base in Q3

Fund management at GIFT-IFSC accelerated in FY26 Q3, with higher commitments, rising investor participation and growing traction in newly launched retail schemes

Crude oil prices, competition likely to dull paint makers' margins

Paint stocks slipped in FY26 Q3 as weak decorative demand, intense competition and rising crude oil prices outweighed hopes of a volume-led recovery

Wire & Cable stocks rally up to 34% in 1 month; Polycab, KEI log new highs

Infrastructure development, housing growth, electrification and the ongoing shift towards organized and compliant products continue to support the demand, said RR Kabel.

Lenskart zooms 52% from listing day low; hits new high in weak market

The stock price of Lenskart hit a new high of ₹541.45 and was quoting higher for the third straight day, surging 12 per cent during this period.

Bharti Airtel hits over 4-month low, down 2%; what's making Street nervous?

Investing in the NBFC business is non-core to the telecom business, hence, analysts may consider it a slight negative from a capital allocation perspective.

Sai Life soars 25% in 5 weeks, hits record high in weak market; here's why

ICRA expects Sai Life Sciences to maintain strong growth momentum over the medium term on the back of a healthy growth outlook for the industry, good product mix and deepening customer engagement.

Risk-reward tilting towards higher exposure to equities: Mihir Vora

Q3FY26 marked a good cyclical improvement in growth, though it may need one or two quarters to call it a decisive earnings inflection, said Vora